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1. Introduction
Indigenous to the Cape region of South Africa [1], Buchu is an aromatic plant known for its
essential-oil producing ability and its multiple healing properties. Known taxonomically as
Agathosma betulina and Agathosma crenulata [1], its traditional benefits have made their way
from Africa to the Western world.
The word “Buchu” originated from the Khoi-San people of southern Africa, and was a word
used in reference to any plant that could be dried or powdered [2]. Nowadays, the name Buchu
refers to the abovementioned Agathosma species. Previously known as Barosma betulia, the
name originates from the word Barosma (Greek) meaning “heavy smell” and the word betulina
(Latin) which means “birch-like”, a word used in reference to the serrated birch-like appear‐
ance of the leaves [3].
There are 150 Agathosma species that are indigenous to South Africa, and of these, A. betulina
and A. crenulata are the more renowned herbs [4]. These are used internationally and locally
for a variety of medicinal purposes.
Agathosma betulina is a shrub that is well adapted to grow in dry regions [1]. The leaves have
round oil glands found scattered across the leaf, which release an aromatic golden oil with a
sweet peppermint-like odour [2]. Agathosma crenulata is an aromatic, single-stemmed shrub,
which can be found growing in the mountainous regions of the Western Cape [5]. Its dark
green leaves release a pale oil with sharp pulegone tones [2].
Fractionation of Buchu by distillation, crystallisation and chromatography releases an oil with
many constituents [6]. Agathosma betulina contains the major volatile compounds limonene,
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menthone, diosphenol and one of its isomers (ψ)-diosphenol, and l-pulegone [7]. Aganthosma
crenulata contains the same main constistuents, but has trace amounts of diosphenol and larger
amounts of l-pulegone [7]. These are responsible for the odour, flavour and medicinal
properties of Buchu oil [8]. Two monoterpene thiols are accountable for the distinguishing
odour of Buchu oil, one being 9-mercapto-p-menthan-3-one [6]. This sulphur-containing
terpene is essential to the aroma and flavour of the plant [6].
True to its description of being a multi-purpose specie, Buchu has long been used as an
antiseptic, an anti-inflammatory agent, for urinary problems including maladies such as
haematuria, calculi, kidney disease and infections of the bladder, prostate and urethra [9].
Today it is also used to stimulate perspiration in rheumatic disease and gout, as a digestive
tonic [9] which treats cholera and stomach complaints, an antispasmodic, an antipyretic, as a
treatment for colds and flu, and most importantly, as a diuretic. In current Pharmacopoeias,
it is listed as a diuretic and a urinary tract antiseptic [2]. It is also listed as a treatment for
arthritis, cellulite, nausea and diarrhoea, flatulence, prostatitis and UTI’s [1, 2, 9].
A number of Buchu preparations are used to deliver it to the body. It may be prepared as a
brandy, a tincture (an alcohol or aqueous solution), a tea, or soaked in vinegar [9]. The vinegar
can be used for external applications to treat bruises, contusions, sprains and fractures, to clean
wounds and to treat rheumatism [10]. The Khoi-San used the plant as an ‘antibiotic repellent’
to repel insects and mixed it with oil to use as a moisturiser, which was essential in their natural
environment and desert climate surroundings [9]. Topical application allowed entry of the
active ingredients of Buchu oil through the skin and provided antibacterial and antifungal
properties, and also acted as an insect repellent and deodarant [9].
Buchu has a long-standing traditional use, but it has made its way into the fragrance and
flavour industries due to its sulphur-containing compounds and sensory properties [2]. It is
used to enhance fruit flavours and fragrances, and boost blackcurrant-like flavours. It has a
naturally minty, sweet berry, apricot, peach and green herbal taste, and its oils are used in
perfumes and colognes [2].
The list of ailments Buchu is capable of counteracting and the multitude of its historical and
current uses are what help to define it as an ethnomedicinally important product, making it
an outstanding phytomedicine and natural product to stave off illnesses (see Table 1).
2. Pharmacological activity
2.1. Diuretic activity
Diospenol is responsible for the diuretic action of Buchu [3]. There is no explanation of the
mechanism of action, but the available literature states that diosphenol acts by irritating the
gallbladder, causing the production of urine [18]. Buchu also contains flavonoids that induce
urine production [11].
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2.2. Antimicrobial activity
Buchu essential oils and extracts were analysed to assess the antimicrobial activity of the plant.
The essential oils and extracts were found to be active against the selected pathogens, namely
Staphylococcus aureus, Bacillus cereus, Klebsiella pneumonia and Candida albicans [12, 13].
Buchu extracts have a good antibacterial activity, and has been found to be more active against
gram positive than gram negative bacteria [12, 13]. Buchu was found to affect the development
of biofilms by preventing attachment of bacteria to the polyvinyl chloride surface2. This was,
however, not the case with the fungus (C. albicans), as exposure to the extracts improved the
attachment to the surface, allowing the formation of a biofilm [2]. The more well known Buchu
species are thus effective against bacteria, but not against fungi. There is, however, a less
extensively researched member of the Agathosma family called A. arida that is effective against
Candida albicans [1]. Agathosma species have been found to contain coumarins, phenolic
substances with benzene and α-pyrone rings [14]. A number of these compounds have been
found to be active against microbials by stimulating macrophages, allowing the plant to have
an indirect ability to eliminate infection [14].
2.3. Anti-oxidant activity
Free radicals are molecules with one or more unpaired electron(s) [15] that are highly reactive,
attacking nearby stable molecules to gain an electron. The two forms of free radicals are reactive
oxygen species (ROS) and reactive nitrogen species (RNS) [15]. Free radical scavengers are
known as antioxidants, and these assist in keeping free radicals at physiologically homeostatic
levels [15]. Polyphenolics in plants are scavengers of free radicals, allowing them to act as anti-
oxidants [16]. These compounds act via several mechanisms to reduce free radicals, and make
wonderful antioxidants due to the hydrogen donating ability of the phenolic groups [16].
Members of the Agathosma specie have been found to contain flavonoids such as diosmin,
hesperidin,rutin, quercitin, mucilage and resins which have extensive anti-oxidant proper‐
ties1. These are some of the compounds that give the Buchu plant its anti-oxidant ability,
allowing it to be effective against many ailments that result from an increase in oxidative stress.
2.4. Anti-inflammatory activity
Buchu oil contains limonene, a monoterpene hydrocarbon with anti-inflammatory properties
[12, 13]. Essential oils found in Agathosma have been found to inhibit the synthesis of
leukotrienes by blocking synthesis of the key enzyme 5-lypoxygenase. By doing so, it reduces
inflammation by preventing the initiation and maintenance of the inflammatory process,
thereby limiting an infection and preventing its progression [2]. Limonene has also shown to
be effective in reducing cyclooxygenase 1 and 2 biosynthesis [2], reducing the proinflammatory
agents prostaglandins and leukotrienes from being synthesised, reducing inflammation.
2.5. Toxicity
The Buchu plant should be used at low dosages for most purposes as it contains diosphenol,
a compound known to be toxic at higher doses [1]. Pulegone, another compound found in
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Buchu, is hepatotoxic [2]. It has been found to reduce the levels of glutathione, a substance
used by the liver in several detoxification steps [2], which would allow the accumulation of
toxins within the liver. The depletion of glutathione and the excess amounts of pulegone found
at high dosages lead to hepatocellular necrosis. Care should thus be taken when Buchu is
consumed to ensure that the maximal therapeutic benefits are acquired, without any of the
unwanted toxic effects.
3. Buchu and the reproductive system
The benefits of Buchu may be applied to treat ailments of the reproductive system. As
previously sited, Buchu is used as a urinary tract antiseptic and as an anti-inflammatory agent
[2], thereby reducing the inflammation seen in UTI’s and treating infections of the urethra and
prostate. Buchu has many direct and indirect effects on the reproductive system via its ability
to act as a diuretic, an anti-oxidant, anti-microbial and an anti-inflammatory agent. The ability
of Buchu to do this will be looked at in more detail below, focussing on its actions in Benign
Prostatic Hypertrophy/Hyperplasia (BPH), prostatitis, in UTI’s and on male fertility.
3.1. Benign prostatic hypertrophy/hyperplasia
BPH is the non-malignant enlargement of the prostate, and is the most common benign tumour
in men over the age of 60 [17]. BPH has many predisposing factors, which include age,
ethnicity, medical and family history and lifestyle factors such as cigarette smoking [17]. Men
who have suffered from chronic diseases such as hypertension, coronary artery disease and
diabetes mellitus are at risk of developing BPH [17].
The prostate is an exocrine gland [18] composed of fibromuscular tissue in a network of glands
embedded in stroma [19]. Androgens are essential to growth of the prostate during early
development, purberty and aging [20]. Androgens do not essentially cause BPH, but have been
found to play a role in hypertrophy of the prostate along with other factors such as aging, diet,
an increase in inflammatory mediators, hormones and oxidative stress [19].
BPH is characterised by nodular overgrowth of the epithelium and fibromuscular tissue [18]
of the prostate, with the differentiation of fibroblasts into myofibroblasts being the hallmark
of tissue remodelling [18] in the disease. Increased deposition of collagen in the ultrastruscture
of the penis and the loss of smooth muscle causes urethral obstruction [21], causing a list of
clinical symptoms related to urinary tract obstruction.
The pathophysiology of BPH is multifaceted, with local and endocrine factors being involved
[17]. One of the main instigators is age-related changes to sex steroid hormone levels which
leads to alterations in the metabolism of androgens locally. This disrupts the growth factor
signalling pathways which interact with the stroma/epithelium, promoting tissue remodelling,
leading to an increase in the size of the prostate [17]. The remodelled epithelium has an altered
production of cytokines and chemoattractants, which encourages inflammation of the prostate
and the production of ROS and RNS. With the increased proliferation of stromal and fibro‐
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muscular cells comes an increased demand of nutrition and oxygen to be delivered to the
prostate [17]. This leads to local tissue hypoxia, promoting neovascularisation to cope with the
increased demand for blood flow, and the production of ROS [17]. The increase in ROS leads
to further fibroblast to myofibroblast differentiation, perpetuating the cell proliferation cycle
and resulting in a further increase in prostate volume.
The roles of other steroidal hormones [20] have been proposed in the pathophysiology of BPH.
The reason for this stemmed from the finding that prostatic cells continue to grow, even in the
face of declining androgen levels [23]. This led to the rationale that other factors being secreted
by the testes may stimulate growth or even sensitize cells of the prostate to the actions of
androgens [23]. As men age, the increase in their body weight increases the amount of adipose
tissue within the body, leading to an increase in circulating oestrogen levels [24]. This is evident
in the levels of free estradiol found circulating in the bloodstream, which remains constant due
to the age-related increases in body weight [25, 26]. Adipose tissue causes increased secretion
of the enzyme aromatase, which stimulates the conversion of androgen to oestrogen. Increased
circulating oestrogen levels stimulate the increased proliferation of cells seen in BPH as
oestrogens have been found to increase the number of prostatic epithelial and stromal cells [27,
29]. Oestrogen also has an indirect effect on the increase in prostate volume through its role in
mediating the alterations in other circulating serum hormones [20].
The changes seen in androgen levels with age disrupt the interaction of growth factors with
prostate cells [22]. The growth of prostate cells is enhanced by the production of growth factors,
which are supplied to the prostate via circulation [17] or locally through autocrine production
by stromal cells [18]. The locally produced growth factors control cell differentiation and
proliferation, and matrix protein production through a network that is interactive, providing
for a negative feedback control mechanism that controls normal cell growth [18]. Any disrup‐
tion in this network leads to abnormal proliferation and stromal hyperplasia [18], which
manifects as BPH. Stromal cell proliferation is enhanced by fibroblast growth factors (FGF 1
and 9), insulin-like growth factors (IGF I and II) and transforming growth factor β (TGFβ1)
[18]. Expression of these growth factors is upregulated in BPH and are a mechanism which
may be altered to reduce accumulation of prostatic cells.
The prostate is located at the neck of the bladder, enveloping the urethra [17]. This location
plays a role in the obstructive symptoms seen in patients with BPH, which also correlate with
the size of the prostate [17]. There are two components of prostatic enlargement that play a
role in obstruction of the bladder outlet which lead to lower urinary tract symptoms, namely
static and dynamic [17].
The static component is related to enlargement of the prostate which is attributed to the
nodular proliferation classically seen in benign prostatic hypertrophy and hyperplasia [17].
This component accounts for the symptoms related to obstruction of the lower urinary tract
seen in cases of BPH. The dynamic component related to the tone of prostatic smooth muscle
[17]. Smooth muscle accounts for a rather large percentage of prostatic volume in BPH [17].
These provide binding sites for α1-adrenoreceptors, making the prostate susceptible to changes
in adrenoreceptor signalling. α-adrenergic signalling has a significant influence on survival of
stromal cells of the prostate and on the activity of smooth muscle cells in the prostate and the
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rest of the body [17]. α-adrenergic signalling alters expression of TGFβ1 and extracellular matix
turnover [18].
BPH presents clinically with lower urinary tract symptoms such as frequent urination, nocturia
(frequent urination at night), the feeling of a full bladder even after voiding, post urination
dribbling, weak urine stream and difficulty initiating urination [30]. It is associated with
serious morbidity and may lead to complications which include acute urinary retention, and
a reduction in the quality of life [17].
3.2. Inflammation in BPH
A substantial number of inflammatory cells and pro-inflammatory cytokines have been found
to be involved in prostatic cell proliferation [19]. The prostate is generally populated by a small
amount of T and B lymphocytes, mast cells and macrophages [19]. These are chronically
activated in BPH and release pro-inflammatory cytokines such as Interleuken 2( IL-2),
Interferon gamma (IFN-γ) and TGFβ, which stimulate growth of the fibromuscular stroma
[19]. Cytokines released by neighbouring cells stimulate the release of cyclo-oxygenase 2
(COX-2) in prostatic epithelial cells, increasing the cell turnover within the prostate [31, 32].
The local hypoxia stimulated by high cell turnover in BPH brings about the release of ROS
which act as inflammatory mediators, causing enlargement of the prostate via stimulating
differentiation of fibroblasts to myofibroblasts [33]. Local hypoxia also stimulates the release
of growth factors and cytokines by stromal cells, including IL-8, vascular endothelial growth
factors, fibroblast growth factors (FGF-2 and 7) and TGFβ [19]. TGFβ regulates stromal cell
proliferation and differentiation in BPH, and is a key factor in the control of prostatic growth
by androgens [34].
The prostate gland’s immune response is mainly a cell mediated one, with regulatory T cells
found in the stromal tissue and cytotoxic T cells in the gland’s epithelia [35]. The accumulation
of activated lymphocytes seen in inflammation of the prostate contributes to the development
of BPH by causing tissue destruction and subsequent tissue rebuilding [20]. The cytokines
produced may drive growth factor production leading to angiogenesis and cell proliferation
as a “wound healing” mechanism [20]. The damage induced by inflammation of the prostate
is thus a chronic process of wound healing where the excessive proliferation of prostatic cells
leads to a cyclic reactivation of inflammation within the prostate [20]. This hyperproliferation
and wound healing leads to the formation of prostatic nodules seen in benign prostatic
hypertrophy/hyperplasia [19]. Inflammation leads to prostatic enlargement by stimulating
growth of the prostate directly or indirectly by reducing apoptosis [19].
Whilst the mechanism of how inflammation leads to the pathogenesis of BPH is well under‐
stood, the origin of the inflammation is not as clearly understood [19]. Numerous aetiologies
have been brought forward, including bacterial infections, an autoimmune response, urine
reflux combined with chemical inflammation, hormones, diet and any combination of these
[19]. The origin thus seems to be multifactorial [19]. It has been proposed that constant injury
to epithelial cells leads to the loss of its function as an effective barrier, facilitating the passage
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and growth of infectious agents, which ultimately leads to further stimulation of the inflam‐
matory response [19].
Inflammation of the prostate increases the risk of urinary retention, which suggests that the
inflammatory processes occurring in BPH lead to lower urinary tract symptoms [19].
Prostatic inflammation is a possible target for the prevention and treatment of BPH. Phyto‐
therapy has become a popular treatment modality for BPH, and the anti-inflammatory
properties of Buchu may be applied to help alleviate inflammation found in BPH. The presence
of essential oils and limonene in buchu oil can inhibit the synthesis of leukotrienes by blocking
synthesis of the enzyme 5-LOX2. This will reduce inflammation by preventing the initiation
and maintenance of inflammatory processes, thereby limiting an infection and preventing its
progression2. Buchu can also prevent the attachment of bacteria to internal surfaces, inhibiting
biofilm formation2. The flavonoids found in buchu may also modulate of inflammation and
strengthen connective tissue, reducing inflammation and any downstream effects that it may
have. The reduction in inflammation can assist in reducing inflammation-induced damage
seen in prostatic tissue, putting an end to chronic would healing that is activated to repair the
cells damaged by inflammatory processes. It will also diminish inflammation-based tissue
remodelling and prevent further enlargement of the prostate.
3.3. Oxidative stress in BPH
Oxidative stress is a condition caused by the imbalance between free radicals and free radical
scavengers [15]. Free radicals are molecules with one or more unpaired electron(s) [36] that
are highly reactive, attacking nearby stable molecules to gain an electron [15]. The molecule
from which the electron was acquired becomes damaged, and it itself may initiate events that
lead to damage of surrounding cells [37]. Free radicals are present at physiological concentra‐
tions which help maintain homeostasis via their actions as signal transducers [38]. Free radicals
come in two common forms, i.e. ROS and RNS [15]. ROS include the superoxide ion, hydrogen
peroxide, the peroxyl and the hydroxyl radical [39]. Reactive nitrogen species include nitric
oxide, nitrous oxide, peroxynitrite, peroxynitrous acid and the nitroxyl anion, and are
considered to be a subsection of ROS [39]. Free radical scavengers are known as antioxidants,
and these assist in keeping free radicals at physiologically homeostatic levels [15]. By doing
this, they help to prevent any pathological effects that may be activated by the development
of oxidative stress, where ROS exceed the number of antioxidants due to increased ROS,
decreased levels of antioxidants, or both [15].
The body produces ROS on a daily basis via metabolic processes that occur in a normal cell
[40]. ROS are generated endogenously by mitochondria and through metabolic and inflam‐
matory processes, but are also introduced into the body via external sources [40]. Physiological
levels of ROS are essential to the regulation of many biological processes [40]. Increased
generation of ROS is related to tissue injury and DNA damage, which are processes found in
cellular proliferation, aging, infections and mutations in mitochondrial DNA [40]. Increased
levels of ROS have also been associated with neoplastic transformation, abnormal cell
proliferation and growth [40].
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Androgens have been found to increase oxidative stress in the prostate gland [41]. Pathological
levels of ROS bring about lipid peroxidation, apoptosis and DNA damage [15]. Lipid peroxi‐
dation is one of the main signs of oxidative damage, and has been found to stimulate alterations
in membrane structure and has been linked to enzyme inactivation [41]. ROS cause this by
abstracting a hydrogen atom from side chains of fatty acids in the cell membrane, initiating
lipid peroxidation which has been found to enhance carcinigenesis [41].
Intracellular changes in the levels of ROS occur during proliferative, apoptotic and senescent
processes, which can lead to the activation of signalling pathways [40]. As mentioned previ‐
ously, changes in tissue oxygenation during these processes causes and upregulation of
cytokines and growth factors, which trigger prostatic cell proliferation, prostatic growth and
inflammation. These processes themselves are a source of oxidative stress, which then leads
to further proliferation and the initiation a chronic inflammation. The presence of ROS is thus
an essential component in the pathogenesis of BPH when present at high levels within the
prostate. This will help reduce ROS levels to physiologically homeostatic levels, allowing them
to carry out their functions as signal transducers without activating any pathological mecha‐
nisms.
Endogenous antioxidant levels decrease with age [42], and this is compounded by other age-
related changes which ultimately lead to the manifestation of BPH. Oxidative stress can lead
to cell mutations, which may lead to carcinogenesis and remodelling of the gland’s internal
structure [43]. BPH is an alternative, benign pathway of unregulated prostatic growth which
is encouraged by inflammatory mediators and increased oxidative stress [41]. Management of
oxidative stress is thus an imperative step in the management of BPH [41].
Management of oxidative stress is also an important factor in the prevention and treatment of
BPH [41]. Buchu is an antioxidant-rich natural remedy that may be used to reduce oxidative
stress. The polyphenolics contained within the plant scavenge free radicals, allowing them to
act as anti-oxidants1. The hydrogen donating ability of the phenolic groups1 will help reduce
the bulid up of ROS. By donating hydrogen groups, these polyphenolics will stabilise free
radicals, preventing them from attacking nearby cells to acquire it.
An increase in free radicals stimulates cyclooxygenase(COX) [44], a key enzyme in initiantion
of the inflammatory process. Increase COX activity stimulates the production of an array of
pro-inflammatory substances called prostaglandins. In patients with BPH and prostatitis there
is an increased production of cyclooxygenase 2 (COX-2) and a reduction in the levels of
prostaglandin E1 [44]. Free radical scavengers, particularly hydroxyl radical scavengers,
suppress the over expression of COX and prostaglandin synthesis [44]. Ethanolis extracts of
Buchu (Agathosma betulina) possess an inhibitory effect on COX-2 synthesis [44]. This
inhibition will, as a consequence, suppress the inflammatory response and reduce hypertro‐
phy/hyperplasia and inflammation of the prostate, which is the goal of antioxidant treatment.
Reducing levels of ROS allows Buchu to interrupt the pathogenesis of BPH by reducing tissue
injury, DNA damage, neoplastic transformation, and activation of growth factors that lead to
abnormal cell proliferation and growth [40]. A diet rich in antioxidants such as vitamins A, C
and E may also be prescribed to work in unison with Buchu to reduce oxidative stress.
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4. Urinary tract infections
UTI’s have a varied incidence that is dependent on age, sex and predisposing factors [45]. UTI’s
are an uncommon occurrence in healthy young men, but incidence does increase with an
increase in age due to predisposing factors and urological abnormalities [45].
The most common cause of UTI’sare bacteria, the most common being Escherichia coli,
Klebsiella pneumonia, enterococci and Staphylococcus epidermidis, to name a few [45].
Bacteria causing UTI’sin men have been found to reach the urinary tract via an ascending route
[45]. The bacterial flora found around the region of the anus is a reservoir for potential
pathogens of the urinary tract [45]. Invasion of the urinary tract is lead by colonisation of the
opening of the urethra, followed by adhesion and attachment to the epithelial lining of the
urethra, with growth of bacteria on the urethral surface leading to ascension of bacteria into
the urinary tract [45]. Invasion of the urethra by bacteria is difficult in men due to the distance
between the opening of the urethra and the perianal region where the bacteria causing UTI’sare
known to reside, the length of the urethra and the presence of prostatic fluid in the urethra,
which is known to have bactericidal activity [45].
Co-infection of the prostate in patients with UTI’sis unknown [45], but a mechanism has been
suggested. Reflux of urine into ducts of the prostate lead to the retrograde transfer of bacteria
from the urethra into the prostate, bringing about infection of the prostate gland (bacterial
prostatitis) [46].
Men with UTI’sare usually predisposed to them by functional or structural abnormalities [47,
49]. Lesions of the urinary tract which predispose men to UTI’sinclude bladder outlet obstruc‐
tion, bladder stones, stricture of the urethra, cancer of the bladder and kidney stones [50].
Signs and symptoms of UTI’sinclude frequency, pain on urination, flank pain and/or costo-
vertebral angle tenderness, which is tenderness in the area overlying the kidney [45].
Lower UTI’sare related to erectile dysfunction and BPH [51]. This interaction may be affected
by extraneous variables such as diabetes, aging and coronary artery diseases such as athero‐
sclerosis, but it was found to be independent of these variables when the co-morbidities were
controlled for [51]; the association between lower UTI’s(UTI) and erectile dysfunction remains.
Men who are found to have more severe lower UTI’s have more severe erectile dysfunction
[51]. The mechanism that gives rise to this interaction is obstruction of the urethra which is
propagated by collagen deposition in the penile ultrastructure and the subsequent loss of
smooth muscle [2. The loss of smooth muscle leads to the reduction in erectile tissue, resulting
in erectile dysfunction.
Buchu has been found to have antimicrobial activity against bacteria that cause urinary tract
infections, i.e. Staphylococcus aureus and Klebsiella pneumonia.
Flavonoids found in buchu may modulate inflammation and strengthen connective tissue.
They may be used in the acute and long-term use for chronic or recurrent UTI, reducing the
symptoms caused by UTI’s [52]. The diuretic actions of Buchu will also assist in the reduction
of inflammation by helping to flush bacteria out of the urinary tract through its ability to
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increase urinary output [52], serving to reduce colonisation of the urethra by bacteria, reducing
the duration of the UTI.
Buchu may be used in the form of a herbal tincture or a herbal tea. The tincture will deliver
adequate quantities of the herb allowing its actions to be distributed throughout the body. The
tea will support the herbal action of the tincture and simultaneously increase fluid intake [52].
Buchu may be used alone or in combination with other plants. In combination, the synergistic
interactions of the extracts found in buchu and those of other plants will produce a better
therapeutic effect in the treatment of a variety of ailments, or, in this instance, in the treatment
of UTI’s[44]. Antibiotic resistance is rife, and is the cause of a prolonged disease course. A
combination of antimicrobial agents helps prevent resistance to antibiotics, increases the
spectrum of activity and may even reduce the side effects of therapy [44]. A combination of
the plants Agathosma crenulata, Dodonaea viscose and Eucalyptus globules produces a broad
spectrum and enhanced antimicrobial activity [44]. Combination of these plants in a 1:1:1 ratio
provides additive and synergistic effects [53] where the extracts of each plant act via multiple
mechanisms to reduce the number of disease causing microbials. The mixture of bioactive
constituents target numerous target sites and work in a synergistic manner [53]. The combi‐
nation of these plants give an additive anti-inflammatory, anti-fungal, analgesic, antibacterial
and antiviral effect [54, 55].
By preventing and reducing colonisation of the urinary tract that leads to urinary tract
infections, other co-morbidities associated with UTI’s such as erectile dysfunction, prostatitis
and erectile dysfunction may be simultaneously prevented.
5. Fertility and ROS
Physiological levels of free radicals are essential in the regulation of sperm maturation,
capacitation and hyperactivation, acrosome reaction and sperm-oocyte fusion [15]. ROS can
make their way into the seminal plasma where they have a regulatory and a damaging an
effect on spermatozoa. Leukocytes and immature spermatozoa are sources of ROS within the
seminal plasma [15]. Leukocytes produce ROS as part of their mechanism to clear the body of
infections [56], but during an infection, increased production and chemotaxis of leukocytes
leads to an increase in ROS and a reduction in the antioxidant called superoxide dismutase
[57]. This results in oxidative stress which has negative effects on the function of spermatozoa
[15]. The changes in sperm parameters brought about are a reduction in motility and in the
fertilisation capacity [58, 59]. The presence of excess cytoplasm in immature spermatozoa leads
to activation of the NADPH system, which donates electrons to free radicals [13], allowing
them to build up within the seminal plasma. This excess of free radicals leads to an increase
in ROS and the disadvantages thereof.
Exogenous sources of ROS allow pathological amounts of ROS to build up within the seminal
plasma [15]. Environmental pollutants increase ROS in testes, causing oxidative stress, DNA
damage and impaired sperm production [15]. Cigarette smoking allows nicotine to make its
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way into the seminal plasma, which has been associated with the production of free radicals
and a decrease in antioxidant function [15]. Cigarette smoking also increases concentrations
of leukocytes in seminal plasma [15]. Excessive intake of alcohol increases ROS while decreas‐
ing antioxidants due to increased ethanol metabolism [60]. Spinal cord injury is associated with
higher levels of ROS and higher numbers of leukocytes, both of which are known to contribute
to oxidative stress, leading to reduces sperm motility and poor sperm morphology [61, 62].
Dilatation of veins in the plexus surrounding the spermatic cord (varicocele) is associated with
increased levels of ROS, with a concomitant decrease in sperm function [63]. Higher quantities
of nitric oxide have also been found in men with varicocele, and these men have also been
found to have higher markers of oxidative stress [64].
As previously stated,  ROS have both physiological  and pathological  roles.  Physiological
levels of ROS have been found to play a vital role in normal sperm function [15]. ROS are
signalling molecules in many processes which allow fertilisation [15]. ROS are essential in
sperm maturation as they have been shown to stabilise sperm chromatin, which is required
to maintain genetic integrity [15]. Capacitation, a process which occurs in the female genital
tract,  is  a maturation process which gives sperm the ability to gain hyperactive motility
and  the  potential  to  carry  out  an  acrosome  reaction  [15];  both  of  which  are  vital  for
fertilisation to take place. Capacitation is a series of molecular changes that brings about
membrane hyperpolarisation, protein phosphorylation and an increase in pH and cAMP
[65]. Hyperactivation, a subsection of capacitaion, provide spermatozoa with the ability to
move  through  cervical  mucous  and  to  penetrate  cumulus  cells  of  the  oocyte  [15].  The
acrosome  reaction,  which  is  the  release  of  proteolytic  enzymes  contained  within  the
acrosomal cap, helps to degrade the extracellular matrix of the zona pellucida [65].  This
allows spermatozoa to  burrow through the  zona pellucida,  allowing penetration of  this
layer to permit fusion with the oocyte. Physiological levels of ROS are also essential for
sperm-oocyte  fusion [15].  Fluidity of  the sperm membrane is  required to  fusion to  take
place [66].  This  is  acquired by spermatozoa through capacitation and acrosome reaction
[15], processes which are both assisted by the presence of ROS. Membrane fluidity allows
sperm to fuse with the oocyte, allowing successful fertilisation.
Pathological levels of ROS are detrimental to sperm function [15]. An imbalance between
ROS and antioxidant defence mechanisms results in pathological processes to be initiated.
ROS cause damage to proteins,  lipid molecules and DNA [67].  Lipid peroxiation causes
loss of fatty acids from sperm plasma membranes, which affects the structure and func‐
tion (i.e. fluidity, transport processed, receptor transduction) of spermatozoa, impairing the
functional  parameters  of  sperm  and  their  ability  to  fertilize  [67,  68].  Sperm  is  usually
resistant  to  DNA  damage  due  to  the  tight  packaging  of  DNA  material  and  the  innate
antioxidant  defense  mechanisms  in  place  [69].  ROS  causes  DNA  damage  and  leads  to
infertility. Nitric oxide and hydrogen peroxide have been found to induce DNA damage,
which brings about DNA fragmentation and reduced sperm parameters (i.e. motility, and
morphology) [70, 73]. The impaired the ability of the Y chromosome to repair DNA strand
breaks  makes  spermatozoa  more  vulnerable  to  DNA  damage  [74].  Damage  to  cellular
components initiates apoptosis. Abnormal spermatozoa are regularly removed via program‐
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med cell death, which is assisted by the presence of ROS [75]. ROS activate mitochondri‐
al  release of cytochrome c,  which ultimately activates caspases which leads to apoptosis
[76, 78]. Hypochlorous acid is also known to oxidise cellular components, directly activat‐
ing apoptosis [78]. Also, high temperatures within the male reproductive system have been
correlated to higher levels of ROS [13].
Antioxidants have been explored as possible therapeutics that may lead to a reduction in levels
of ROS [15]. Antioxidant therapy has been shown to reduce oxidative stress, resulting in
reduced DNA damage and apoptosis. Antioxidants may be used to keep free radicals at levels
that are appropriate for physiological function, while reducing the levels that bring about
unwanted pathologies and infertility [15].
Buchu is well known for its antioxidant properties. As discussed above, it has been shown to
contain factors which assist in the antioxidant activity of the plant. By using this plant in small
therapeutic doses, Buchu may be effective in staving off excess build up of free radicals,
decreasing the negative effects on the function of spermatozoa that lead to infertility.
6. Conclusions
Buchu has been utilised in southern Africa for millennia by the Khoi-San people indige‐
nous  to  the  region for  a  multitude of  daily  uses  and a  plethora  of  ailments.  It  is  a  re‐
nowned herb whose traditional benefits have made their way from Africa to the Western
world. There are 150 Agathosma species that are indigenous to South Africa, and of these,
Agathosma  betulina  and  Agathosma  crenulata  are  the  most  well  known.  True  to  its
description of being a multi-purpose specie,  Buchu has long been used as an antiseptic,
and anti-inflammatory, for urinary problems including maladies such as haematuria, calculi,
kidney disease and infections of the bladder, prostate and urethra. Buchu’s pharmacologi‐
cal  profile  allows  it  to  be  used  for  its  diuretic,  antimicrobial,  anti-inflammatory  and
antiseptic purposes. Its uses today have spread beyond its medicinal applications, as this
compound has made its way into the fragrance and flavour industries where it is used to
enhance fruit flavours and boost fragrances. Buchu’s biological profile allows it to be used
to alleviate ailments of the reproductive system. Its uses in inflammation, oxidative stress
and in the removal of pathogenic species from the body have allowed it to be effective in
treating disorders such as BPH and UTI’s. Its antioxidant properties may be used to prevent
infertility through its potential to help keep ROS/RNS at physiological levels, allowing them
to regulate sperm function without allowing pathological levels to be obtained, which can
have detrimental effects on the ability to reproduce. Whilst the advantages of using this
natural product have been known for a substantial amount of time, the use of Buchu has
not made its way into mainsteam markets as definitive research still needs to be done to
substantiate its benefits. Because of all its benefits, it would be a worthy task to look into
all its properties so that maximal benefit may be obtained from its use.
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Author/Study Findings/Uses of Buchu Application/Mechanism of action
Moolla et al, 2007
Anti-oxidant properties
Members of the Agathosma specie contain flavonoids,
i.e. diosmin, hesperidin,rutin, quercitin, mucilage and
resins with extensive anti-oxidant properties
These compounds act via several mechanisms to reduce
free radicals






Buchu essential oils and extracts active against selected
pathogens, namely Staphylococcus aureus, Bacillus
cereus, Klebsiella pneumonia and Candida albicans.
More active against gram positive than gram negative
bacteria
Affects the development of biofilms by preventing
attachment of bacteria
Agathosma species found to contain coumarins,
phenolic substances with benzene and α-pyrone rings. A
number of these compounds have been found to be
active against microbials by stimulating macrophages
Moolla et al, 2007
Lis-Balchin et al, 2001
Shwegler, 2003
Viljoen et al, 2007




infections of the bladder,
prostate, urethra
Oil distilled from Buchu leaves has therapeutic
properties and major uses, including the treatment of
kidney and urinary tract infections, as well as
haematuria and prostatitis




Diospenol is responsible for the diuretic action of Buchu.
Diosphenol acts by irritating the gallbladder, causing the
production of urine.








The Agathosma species has been many applications,
among these are its uses in the treatment of arthritis
and rheuamtism through its ability to reduce uric acid.
Buchu has been listed as a treatment for stomach
ailments and for relief from nausea, diarrhoea and
flatulence
Moolla and Viljoen, 2009
Lis-Balchin M et al, 2001






A number of Buchu preparations are used to deliver it to
the body. It may be soaked in vinegar and used as an
external application to treat bruises, contusions, sprains
and fractures
Used as an antiseptic to clean wounds
Van Wyk et al, 1997
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Two monoterpene thiols are accountable for the
distinguishing odour of Buchu oil, one being 9-
mercapto-p-menthan-3-one. This sulphur-containing
terpene is essential to the aroma and flavour of the
plant
Buchu has a naturally minty, sweet berry, apricot, peach
and green herbal taste, and its oils are used in perfumes
and colognes
Moolla and Viljoen, 2009
Viljoen et al, 2006
Anti-inflammatory
Buchu oil contains limonene, a monoterpene
hydrocarbon with anti-inflammatory properties.
Essential oils found in Agathosma found to inhibit the
synthesis of leukotrienes by blocking synthesis of the
key enzyme 5-lypoxygenase
Limonene also shown to be effective in reducing
cyclooxygenase 1 and 2 biosynthesis
Moolla et al, 2007
Table 1. Table showing the diverse uses and properties of Buchu, which are the properties which help to define Buchu
it as an ethnomedicinally important product
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